Dr. Dimattio is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Halket St
Ste 4750
Pittsburgh, PA 15213Phone+1 412-687-1300
Education & Training
University of Texas at Austin Dell Medical SchoolResidency, Obstetrics and Gynecology, 2016 - 2020
Lewis Katz School of Medicine at Temple UniversityClass of 2016
Certifications & Licensure
PA State Medical License 2020 - 2026
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Preventive Medicine Addiction Medicine
Publications & Presentations
PubMed
- 5 citationsModulation of Morphine Analgesia, Antinociceptive Tolerance, and Mu-Opioid Receptor Binding by the Cannabinoid CB2 Receptor Agonist O-1966.Zachary W Reichenbach, Kelly DiMattio, Suren Rajakaruna, David Ambrose, William D Cornwell
Frontiers in Pharmacology. 2022-01-01 - 75 citationsPhosphoproteomic approach for agonist-specific signaling in mouse brains: mTOR pathway is involved in κ opioid aversion.Jeffrey J. Liu, Yi-Ting Chiu, Kelly M. DiMattio, Chongguang Chen, Peng Huang
Neuropsychopharmacology. 2019-04-01 - 31 citationsIntrinsic relative activities of κ opioid agonists in activating Gα proteins and internalizing receptor: Differences between human and mouse receptors.Kelly M. DiMattio, Frederick J. Ehlert, Lee-Yuan Liu-Chen
European Journal of Pharmacology. 2015-08-15
Journal Articles
- Phosphoproteomic Approach for Agonist-Specific Signaling in Mouse Brains: mTOR Pathway Is Involved in Κ Opioid AversionKelly Dimattio, MD, Nature
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
